Atlas FDA

Exablate 2100/2100 VI System

FDA premarket approval P110039/S008 · decided 2018-01-25

Approval details

PMA number
P110039
Supplement
S008
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Exablate 2100/2100 VI System
Generic name
Ablation system, high intensity focused ultrasound (HIFU), MR-guided
Applicant
Insightec
Date received
2017-09-22
Decision date
2018-01-25
Days to decision
125 days
Decision code
APPR
Product code
NRZ
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Tirat Carmel
Statement
Approval for 1) Software maintenance update to the currently approved clinical software (SW) Versions 6.24 (Windows-XP)/6.241 (Windows-7) used in the Exablate Model 2100/ 2100V1 Type 1.1 / Type 1.11 System (referred to as Exablate Bone or the system). The new software revision will be Version 6.57 (Windows-XP)/6.58 (Windows-7) (6.57 is a set of enhancements to the SW; 6.58 is an update to Windows 7 OS compatibility); and 2) Addition of a water bag as an accessory for acoustic coupling. The water

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.